Fatemeh Kiaee, Majid Zaki-Dizaji, Nasim Hafezi, Amir Almasi-Hashiani, Haleh Hamedifar, Araz Sabzevari, Afshin Shirkani, Zeineb Zian, Farhad Jadidi-Niaragh, Fatemeh Aghamahdi, Mahdi Goudarzvand, Reza Yazdani, Hassan Abolhassani, Asghar Aghamohammadi, Gholamreza Azizi
BACKGROUND: Immunodeficiency, centromeric instability and facial dysmorphism )ICF) syndrome is a rare autosomal recessive immune disorder presenting with hypogammaglobulinemia, developmental delay, and facial anomalies. The ICF type 1, type 2, type 3 and type 4 are characterized by mutations in DNMT3B, ZBTB24, CDCA7 or HELLS gene, respectively. This study aimed to present a comprehensive description of the clinical, immunologic and genetic features of patients with ICF syndrome. METHODS: PubMed, Web of Science, and Scopus were searched systemically to find eligible studies...
June 13, 2020: Endocrine, Metabolic & Immune Disorders Drug Targets